|
Archived NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
05/28/2025 - 12:00am to 05/22/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
05/28/2025 - 12:00am to 05/23/2026 - 11:59pm |
|
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course |
1.50 |
05/29/2025 - 9:00pm to 07/01/2025 - 12:00am |
|
CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice |
1.50 |
05/30/2025 - 9:00pm to 07/01/2025 - 12:00am |
|
Myeloma Masterclass: Applying the Latest Guidelines for Evidence-Based, Equitable Care |
1.50 |
05/31/2025 - 9:00pm to 07/02/2025 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2025 |
1.00 |
06/10/2025 - 12:00am to 06/10/2026 - 12:00am |
|
Smoking Cessation for Patients with Cancer: State of the Evidence |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates in Metastatic Colorectal Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Expanding the Reach of Clinical Trials |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to Systemic Therapy for Differentiated Thyroid Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
CRS and ICANS Management in CAR T/Bispecific Antibody Therapies |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Expansion of Recommendations for Hereditary Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Recorded Presentations from the NCCN 2025 Nursing Program: Advancing Oncology Nursing™ |
|
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Management of Immune Checkpoint Inhibitor-Related Toxicities |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Advances in Antiemesis Management for Patients with Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Facebook
Twitter
LinkedIn
Forward